Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

Clinical trial NCT06933056 · RECRUITING

Trial details

NCT number: NCT06933056
Sponsor: University of Michigan
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Platelet Function and Reactivity Tests

Start date: 2025-09-02
Primary completion: 2026-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.